Health
New combination therapy could help fight difficult-to-treat cancers with common mutations – EurekAlert
UCLA scientists describe a new combination therapy that suppresses the MAPK pathway by holding cancer-driving proteins in a death grip. This combination of two…
LOS ANGELES — Scientists have long known that therapies that target the cancer-driving MAPK pathway are only effective in a handful of cancers with specific mutations in a cancer gene called BRAF, and these cancers that initially respond to the therapy often end up developing resistance to the treatment, resulting in relapse for many patients.
Now, scientists at the UCLA Jonsson Comprehensive Cancer Center describe a new combination therapy that suppresses the MAPK pathway by holding cancer-driving…
-
Noosa News12 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News13 hours agoMotorcyclist dies in crash with truck
-
Noosa News13 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General18 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging